Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction.
Adjusted earnings increased 29% to $2.11 per share from $1.64 per share a year earlier. Analysts were looking for a smaller bottom-line number.
Net income, on an unadjusted basis, came in at $360 million or $0.29 per share, compared to a loss of $1.17 billion or $0.92 per share in the prior-year period.
Read management/analysts’ comments on Gilead Sciences Q3 earnings
Revenues moved up 17% year-over-year to $6.58 billion in the September-quarter and exceeded the market’s prediction. The company’s stock closed Wednesday’s regular trading lower, hut gained during the after-hours session.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
MS Earnings: Morgan Stanley Q1 2025 revenue and earnings beat estimates
Morgan Stanley (NYSE: MS) on Friday reported higher revenues and net profit for the first quarter of 2025. The latest numbers also exceeded analysts’ estimates. The company reported net revenues
WFC Earnings: Key quarterly highlights from Wells Fargo’s Q1 2025 financial results
Wells Fargo & Company (NYSE: WFC) reported its first quarter 2025 earnings results today. Total revenue decreased 3% year-over-year to $20.15 billion. Net income grew 6% to $4.89 billion and
JPM Earnings: All you need to know about JPMorgan’s Q1 2025 earnings results
JPMorgan Chase & Co. (NYSE: JPM) reported its first quarter 2025 earnings results today. Reported net revenue increased 8% year-over-year to $45.3 billion. Managed net revenue was $46 billion, also
